These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 952292)

  • 41. Platelet hypersensitivity induced by cholesterol incorporation.
    Shattil SJ; Anaya-Galindo R; Bennett J; Colman RW; Cooper RA
    J Clin Invest; 1975 Mar; 55(3):636-43. PubMed ID: 1117069
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epinephrine potentiates human platelet activation but is not an aggregating agent.
    Lanza F; Beretz A; Stierlé A; Hanau D; Kubina M; Cazenave JP
    Am J Physiol; 1988 Dec; 255(6 Pt 2):H1276-88. PubMed ID: 3202191
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Abnormal antithrombin III (antithrombin III "Budapest") as a cause of a familial thrombophilia.
    Sas G; Blaskó G; Bánhegyi D; Jákó J; Pálos LA
    Thromb Diath Haemorrh; 1974 Sep; 32(1):105-15. PubMed ID: 4454033
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Global Thrombosis Test (GTT) can detect major determinants of haemostasis including platelet reactivity, endogenous fibrinolytic and thrombin generating potential.
    Yamamoto J; Inoue N; Otsui K; Ishii H; Gorog DA
    Thromb Res; 2014 May; 133(5):919-26. PubMed ID: 24613697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of cyclic AMP in adenosine inhibition of intracellular calcium rise in human platelets. Comparison of adenosine effects on thrombin- and epinephrine-induced platelet stimulation.
    Feoktistov IA; Paul S; Hollister AS; Robertson D; Biaggioni I
    Am J Hypertens; 1992 Jun; 5(6 Pt 2):147S-153S. PubMed ID: 1321639
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circadian variation in platelet function in healthy volunteers.
    Jafri SM; VanRollins M; Ozawa T; Mammen EF; Goldberg AD; Goldstein S
    Am J Cardiol; 1992 Apr; 69(9):951-4. PubMed ID: 1532287
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Autoprothrombin ii-a, thrombin, and epinephrine: interrelated effects on platelet aggregation.
    Herman GE; Seegers WH; Henry RL
    Bibl Haematol; 1977; 44():21-7. PubMed ID: 617782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Platelet aggregation induced in vitro by rabbit plasma clot-associated thrombin, and its inhibition by thrombin inhibitors.
    Gandossi E; Lunven C; Gauffeny C; Roome NO; Berry CN
    Thromb Haemost; 1998 Nov; 80(5):840-4. PubMed ID: 9843181
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Platelet membrane aggregation by platelet aggregation provoking substances].
    Watanabe K; Ando Y; Ikeda Y; Deguchi N
    Rinsho Byori; 1979; Suppl 40():257-67. PubMed ID: 551228
    [No Abstract]   [Full Text] [Related]  

  • 50. Mechanisms of platelet shape change, aggregation, and release induced by collagen, thrombin, or A23,187.
    Kinlough-Rathbone RL; Packham MA; Reimers HJ; Cazenave JP; Mustard JF
    J Lab Clin Med; 1977 Oct; 90(4):707-19. PubMed ID: 333044
    [No Abstract]   [Full Text] [Related]  

  • 51. Plasmin inhibition of platelet function and of arachidonic acid metabolism.
    Schafer AI; Adelman B
    J Clin Invest; 1985 Feb; 75(2):456-61. PubMed ID: 3156149
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibitory effect of hericenone B from Hericium erinaceus on collagen-induced platelet aggregation.
    Mori K; Kikuchi H; Obara Y; Iwashita M; Azumi Y; Kinugasa S; Inatomi S; Oshima Y; Nakahata N
    Phytomedicine; 2010 Dec; 17(14):1082-5. PubMed ID: 20637576
    [TBL] [Abstract][Full Text] [Related]  

  • 53. β-Antithrombin, subtype of antithrombin deficiency and the risk of venous thromboembolism in hereditary antithrombin deficiency: A family cohort study.
    Croles FN; Mulder R; Mulder AB; Lukens MV; Meijer K
    Thromb Res; 2018 Aug; 168():47-52. PubMed ID: 29902631
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Local thrombin synthesis and fibrin formation in an in vitro thrombosis model result in platelet recruitment and thrombus stabilization on collagen in heparinized blood.
    Wagner WR; Hubbell JA
    J Lab Clin Med; 1990 Nov; 116(5):636-50. PubMed ID: 2104522
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro and in vivo functions of thrombin-treated platelets.
    Reimers HJ; Kinlough-Rathbone RL; Cazenave JP; Senyi AF; Hirsh J; Packham MA; Mustard JF
    Thromb Haemost; 1976 Feb; 35(1):151-66. PubMed ID: 785686
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of C-reactive protein on platelet function. II. Inhibition by CRP of platelet reactivities stimulated by poly-L-lysine, ADP, epinephrine, and collagen.
    Fiedel BA; Gewurz H
    J Immunol; 1976 Oct; 117(4):1073-8. PubMed ID: 977942
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of human platelets separated from blood by ADP-induced aggregation.
    Mohammad SF; Reddick RL; Mason RG
    Am J Pathol; 1975 Apr; 79(1):81-94. PubMed ID: 1124800
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Edoxaban, a direct factor Xa inhibitor, suppresses tissue-factor induced human platelet aggregation and clot-bound factor Xa in vitro: Comparison with an antithrombin-dependent factor Xa inhibitor, fondaparinux.
    Honda Y; Kamisato C; Morishima Y
    Thromb Res; 2016 May; 141():17-21. PubMed ID: 26962981
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Demonstration of a plasmatic cofactor different from fibrinogen necessary for platelet release by ADP and adrenaline.
    Cronberg S; Kubisz P
    Thromb Diath Haemorrh; 1970 Dec; 24(3):409-18. PubMed ID: 5503940
    [No Abstract]   [Full Text] [Related]  

  • 60. Diagnostic problems in thromboembolism.
    Odegård OR
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):960-6. PubMed ID: 94892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.